Latest News
Featured News
Select the category
Cancer vaccine data due soon; Glymab developments too
Clinical & Corporate Update: Active Immunotherapy for a Cancer-Free Future
Scancell initiates new arm (Cohort 4) in SCOPE Phase 2 study to evaluate intradermal administration and an accelerated dosing regimen for iSCIB1+
Q&A with Scancell CMO Nermeen Varawalla
Director Dealing
AACR (American Association for Cancer Research) Annual Meeting, April 2025, Chicago, Illinois
Annual Report 30th April 2025
Investor Update: 24 April 2025
Scancell’s new partnership with the NHS Vaccine Launch Pad (CLVP) March 2025
Partnership with NHS Cancer Vaccine Launch Pad Enabling Fast-Tracked Access for Melanoma Patients
Scancell to Present Clinical Data from the Ongoing Phase 2 SCOPE Trial of SCIB1 at 2025 AACR Annual Meeting
AACR 10 (American Association for Cancer Research), February 2025, Los Angeles, California
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.